Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review
In conclusion, exogenous testosterone administration to transgender men was associated with modest increases in BMI, hemoglobin/hematocrit, and LDL‐cholesterol, and with decreases in HDL‐cholesterol. Long‐term studies are needed to assess the long‐term risks of testosterone therapy, particularly as they relate to cardiometabolic risks such as diabetes, dyslipidemia and the metabolic syndrome.
Source: Andrology - Category: Urology & Nephrology Authors: I. Velho, T. M. Fighera, P. K. Ziegelmann, P. M. Spritzer Tags: Original Article Source Type: research
More News: AndroGel | Cardiology | Cholesterol | Diabetes | Endocrinology | Heart | Hormonal Therapy | Hormones | Hypertension | Laboratory Medicine | Liver | Metabolic Syndrome | Study | Urology & Nephrology